Entrada Therapeutics, Inc. · NASDAQ:TRDA

Parmar Kush sold 116,474 Entrada Therapeutics, Inc. shares (Form 4)

Traded Jul 30 to Jul 31, 2026 · Filed Aug 3, 2026

From Jul 30 to Jul 31, 2026, Parmar Kush (Director, 10% owner) sold 116,474 Entrada Therapeutics, Inc. shares at an average US$6.93 for US$807K, leaving 2,846,592 shares. Filed Aug 3, 2026 (Form 4).

Sold
116,474 shares
Price
US$6.93 average (US$6.85 to US$6.93)
Value
US$807K
Holding after
2,846,592 shares (held indirectly)
Trading plan
No
Role
Director, 10% owner

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jul 30, 2026Common StockSale114,756US$6.932,848,310Indirect
Jul 31, 2026Common StockSale1,718US$6.852,846,592Indirect

Source

View original at SEC

Related